Co-administration of CD19 and CD22 CAR-T therapy in pediatric relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia
Years Later, These Kids With Tough Leukemia Are Still in Remission
This retrospective subanalysis evaluated long-term outcomes in pediatric patients with relapsed/refractory Philadelphia chromosome-positive …
Pairing two reprogrammed immune cell therapies gave most kids with an aggressive form of leukemia long-term remission — without a single tre…
